Disclosure Panels Details Page
Breast Cancer Panel - Disclosures as of 04/19/2024
|
Panel Member
(Spouse/Domestic Partner/Dependent) |
Clinical Research Support/Data Safety Monitoring Board | Scientific Advisory Boards, Consultant, or Expert Witness | Promotional Advisory Boards, Consultant, or Speakers Bureau | Employment/ Governing Board, Patent, Equity, or Royalty | Date Completed |
|---|---|---|---|---|---|
| Jame Abraham MD,FACP | Daiichi- Sankyo Co. Pfizer Inc. |
None | None | None | 12/17/2023 |
| Vandana Abramson MD | Eli Lilly and Company Immunomedics, Inc. Roche Laboratories, Inc. Seattle Genetics, Inc. Zentana |
Daiichi- Sankyo Co. Eisai Inc. MacroGenics Signatera |
None | None | 05/04/2023 |
| Rebecca Aft MD,PhD | None | None | None | None | 04/11/2024 |
| Doreen Agnese MD | None | None | None | None | 02/20/2024 |
| Kimberly Allison MD | None | None | None | None | 01/30/2024 |
| Bethany Anderson MD | Miscellaneous | None | None | None | 03/26/2024 |
| Janet Bailey MD | None | None | None | None | 01/02/2024 |
| Marian Birkeland PhD | None | None | None | None | 04/02/2024 |
| Nicole Blankenhorn | None | None | None | None | 03/04/2024 |
| Harold Burstein PhD,MD | None | None | None | None | 02/06/2024 |
| Nan Chen MD | Eli Lilly and Company | Guardant Health SeaGen Stemline Therapeutics |
None | None | 02/27/2024 |
| Helen Chew MD | None | None | None | None | 12/11/2023 |
| Chau Dang MD | Daiichi- Sankyo Co. Genentech, Inc. |
Daiichi- Sankyo Co. Novartis Pharmaceuticals Corporation RACE Oncology |
Daiichi- Sankyo Co. Roche Laboratories, Inc. |
None | 03/23/2024 |
| Sarah DeVincenzo PharmD,BCPS | None | None | None | None | 02/26/2024 |
| Anthony Elias MD | Astellas Pharma US, Inc. C4 Therapeutics Epizyme ImmuneOnco Biopharmaceuticals Infinity Pharmaceuticals, Inc PTC Therapeutics Scorpion |
None | None | None | 03/19/2024 |
| Tanya Fischer MLIS,MEd | None | None | None | None | 12/06/2023 |
| Sharon Giordano MPH,MD | None | None | None | None | 11/26/2023 |
| Matthew Goetz MD | AstraZeneca Pharmaceuticals LP ATOSSA Therapeutics Eli Lilly and Company LOXO Pfizer Inc. Sermonix |
AstraZeneca Pharmaceuticals LP Biotheranostics Blueprint Medicines Eli Lilly and Company Novartis Pharmaceuticals Corporation Pfizer Inc. SeaGen Sermonix |
Clinical Education Alliance Medscape MJH Life Sciences Research to Practice Total Health Consulting |
None | 08/01/2023 |
| William Gradishar MD | Eli Lilly and Company Genentech, Inc. Gilead Sciences, Inc. Novartis Pharmaceuticals Corporation Pfizer Inc. |
AstraZeneca Pharmaceuticals LP Merck & Co., Inc. Pfizer Inc. |
None | None | 12/04/2023 |
| Kristina Gregory MSN,RN | None | None | None | None | 01/10/2024 |
| Evelyn Handel PharmD,BCPS,BCOP | None | None | None | None | 02/02/2024 |
| Kyle Herrmann RN,OCN,BSN | None | None | None | None | 12/11/2023 |
| Erin Hesler | None | None | None | None | 12/22/2023 |
| Rachel Jankowitz MD | None | Biotheranostics | Biotheranostics | Biotheranostics | 11/01/2023 |
| Sara Javid MD | None | None | None | None | 04/12/2024 |
| Jairam Krishnamurthy MD,FACP | None | Agendia BV AstraZeneca Pharmaceuticals LP Biotheranostics |
None | None | 02/02/2024 |
| Rashmi Kumar PhD | None | None | None | None | 12/06/2023 |
| A. Marilyn Leitch MD | Alliance for CLinical trials in Oncology | None | None | Alliance for CLinical Trials in Oncology | 03/11/2024 |
| Janice Lyons MD | None | None | Primum | None | 03/26/2024 |
| Susie McCloskey MSHS,MD | None | None | None | None | 03/28/2024 |
| Melissa McShane MD | None | AstraZeneca Pharmaceuticals LP | None | None | 01/05/2024 |
| Meena Moran MD | None | University of Penn University Penn |
None | None | 02/02/2024 |
| Joanne Mortimer MD,FACP | None | General Electric | None | None | 08/28/2023 |
| Sameer Patel MD,FACS | None | None | None | None | 08/28/2023 |
| Donna Powell CMD,DHSc,RT(T) | None | None | None | None | 03/13/2024 |
| Laura Rosenberger MS,MD | Foundation Medicine Invitae |
None | None | None | 02/11/2024 |
| Hope Rugo MD | Ambryx AstraZeneca Pharmaceuticals LP Daiichi- Sankyo Co. Gilead Sciences, Inc. Hoffmann-La Roche AG/Genentech Lilly Merck & Co., Inc. Novartis Pharmaceuticals Corporation OBI Pharma Pfizer Inc. Stemline |
None | Daiichi- Sankyo Co. Eisai Inc. Mylan/Viatris NAPO sanofi-aventis U.S. |
None | 04/03/2024 |
| Cesar Santa-Maria MD,MSCI | AstraZeneca Pharmaceuticals LP Celldex Therapeutics Genentech, Inc. Merck & Co., Inc. Novartis Pharmaceuticals Corporation Pfizer Inc. |
None | None | None | 12/14/2023 |
| Bryan Schneider MD | Foundation Medicine Genentech, Inc. Pfizer Inc. |
None | None | None | 03/26/2024 |
| Ryan Schonfeld BA | None | None | None | None | 02/05/2024 |
| Mary Lou Smith MBA,JD | None | None | None | None | 01/04/2024 |
| Hatem Soliman MD | None | AstraZeneca Pharmaceuticals LP Eli Lilly and Company Novartis Pharmaceuticals Corporation PUMA SeaGen |
None | None | 12/18/2023 |
| Erica Stringer-Reasor MD | None | AstraZeneca Pharmaceuticals LP Eli Lilly and Company Merck & Co., Inc. Novartis Pharmaceuticals Corporation |
None | None | 01/26/2024 |
| Melinda Telli MD | Arvinas Bayer HealthCare G1 Therapeutics Genentech, Inc. Gilead Sciences, Inc. GSK Hummingbird Biosciences Merck & Co., Inc. OncoSec Medical Pfizer Inc. |
AstraZeneca Pharmaceuticals LP Blueprint Medicines Merck & Co., Inc. Natera Novartis Pharmaceuticals Corporation Replicate |
None | None | 07/30/2023 |
| Mei Wei MD | None | Biotheranostics Gilead Sciences, Inc. |
None | None | 01/24/2024 |
| Kari Wisinski MD | AstraZeneca Pharmaceuticals LP Context Therapeutics Daiichi- Sankyo Co. Genentech, Inc. Novartis Pharmaceuticals Corporation Pfizer Inc. Puma Biotechnology Relay Therapeutics Roche Laboratories, Inc. sanofi-aventis U.S. SeaGen Zymeworks |
AstraZeneca Pharmaceuticals LP Gilead Sciences, Inc. Loxo@Lilly |
None | None | 01/12/2024 |
| Kay Yeung PhD,MD | BioFluidica Dantari Gilead Sciences, Inc. Immunomedics, Inc. Ionis Pharmaceutical Regeneron Pharmactcls SeaGen Zymeworks |
Eversana Kaneka |
Elseiver | Esperion Therapeutics|Ionis Pharmaceuticcal | 05/04/2023 |
| Jessica Young MD | None | None | None | None | 03/18/2024 |